A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3;14)(p21.1;q24.1)

American Journal of Hematology

Volumn 81, Issue 11, 2006, Pages 883-887

  Dinçol, Günçaǧ ^a,b   Öztürk, Şükrü ^a   Palanduz, Şükrü ^a   Tutkan, Güçin ^a   Yildirim, Naciye ^a   Ayer, Mesut ^a   Güvenç, Serkan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Erythroid hypoplasia; Familial translocation t(3; 14)(p21.1; q24.1); FISH; Myelodysplastic syndrome (MDS); Refractory anemia

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN M; RECOMBINANT ERYTHROPOIETIN; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW HYPOPLASIA; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLONAL VARIATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSERYTHROPOIESIS; ERYTHROID PRECURSOR CELL; FAMILIAL DISEASE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GEL ELECTROPHORESIS; HETERODUPLEX ANALYSIS; HUMAN; HYPOPLASIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MEGAKARYOPOIESIS; MYELODYSPLASTIC SYNDROME; MYELODYSPLASTIC SYNDROME WITH ERYTHROID HYPOPLASIA; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REFRACTORY ANEMIA; RETICULOCYTOSIS; SERODIAGNOSIS; T LYMPHOCYTE; THROMBOCYTE COUNT; THYMOMA; TREATMENT OUTCOME;

ADULT; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MYELODYSPLASTIC SYNDROMES; PEDIGREE; RED-CELL APLASIA, PURE; TRANSLOCATION, GENETIC;

EID: 33750576219     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20684     Document Type: Article

References (25)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes, Br J Haematol 1982;51:189-199.
2. Williamson PJ, Oscier DG, Bell AJ, Hamblin TJ. Red cell aplasia in myelodysplastic syndrome. J Clin Pathol 1991;44:431-432.
3. Garcia-Suarez J, Pascual T, Munoz MA, Herrero B, Pardo A. Myelodysplastic syndrome with erythroid hypoplasia/aplasia: A case report and review of the literature. Am J Hematol 1998;58:319-325.
4. Park S, Merlat A, Guesnu M. et al. Pure red cell aplasia associated with myelodysplastic syndromes. Leukemia 2000;14:1709-1710.
5. Stadler M, Germing U, Kliche KO, et al. A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia 2004;18:460-465.
6. Killick SB, Mufti G, Cavenagh JD, et al. A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia. Br J Haematol 2003;120:679-684.
7. Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ. Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol 1997;99:699-705.
8. Shimamoto T, Iguchi T, Ando K, et al. Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. Br J Haematol 2001;114:358-361.
9. Jonasova A, Neuwirtova R, Cermak J, et al. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998;100:304-309.
10. Tamayose K, Sugimoto K, Ando M, Oshimi K. Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts. Blood 2001;97:2524.
11. Mecucci C. Molecular features of primary MDS with cytogenetic changes. Leuk Res 1998;22:293-302.
12. Pedersen B, Norgaard JM, Pedersen BB, Clausen N, Rasmussen IH, Thorling K. Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies. Am J Hematol 2000;64:161-169.
13. Fenaux P. Chromosome and molecular abnormalities in myelodysplastic syndromes. Int J Hematol 2001;73:429-437.
14. Fenaux P, Morel P, Lai JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996;33:127-138.
15. Maserati E, Minelli A, Menna G, et al. Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects. Cancer Genet Cytogenet 2004;148:155-158.
16. Yamamoto K, Hato A, Minagawa K, et al. Unbalanced translocation der(11)t(11;12)(q23;q13): A new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype. Cancer Genet Cytogenet 2004;155:67-73.
17. Cermak J, Michalova K, Brezinova J, Zemanova Z. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q-syndrome from refractory anemia in primary myelodysplastic syndrome. Leuk Res 2003;27:221-229.
18. Barch MJ. ACT Cytogenetics Laboratory Manual, 2nd ed. New York: Raven Press; 1981. pp 127-128.
19. Mitelman F. An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 1995.
20. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-2938.
21. Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol 1996;33:150-162.
22. Gardner RJM, Southerland GR. Chromosome Abnormalities and Genetic Counselling, 3rd ed. New York: Oxford University Press; 2004. pp 59-97.
23. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer. 2005 (http://cgap.nci.nih.gov/Chromosomes/Mitelman).
24. Pai GS, Lewandowski RC, Digamber S, Borgaonkar DS. Handbook of Chromosomal Syndromes. New York: Wiley-Liss; 2003.
25. Entrez Gene: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD =search&DB=gene